Literature DB >> 20925436

Preventability of drug-related harms - part I: a systematic review.

Robin E Ferner1, Jeffrey K Aronson.   

Abstract

'Preventability' is a crucial concept in the literature on adverse drug reactions (ADRs). We have carried out a systematic review in order to identify and analyse the approaches used to define 'preventability' in relation to ADRs. We have restricted this investigation to definitions of preventability and have not dealt with other aspects. We searched MEDLINE (1963-April 2009) and EMBASE (1980-April 2009), without language restriction, for papers in which preventability of ADRs was likely to be defined. We found 234 papers, of which we retrieved 231. Of these, 172 either contained original definitions of preventability or referred to other papers in which preventability was defined. Forty contained no definition, and 19 were not relevant. In the 172 papers selected, we identified eight different general approaches to defining the preventability of ADRs: (1) analysis without explicit criteria; (2) assessment by consensus; (3) preventability linked to error; (4) preventability linked to standards of care; (5) preventability linked to medication-related factors; (6) preventability linked to information technology; (7) categorization of harmful treatments in explicit lists; and (8) a combination of more than one approach. These approaches rely on two general methods: the judgement of one or more investigators or the use of pre-defined explicit criteria; neither is satisfactory. Specific problems include the weakness of consensus as a method (since experts can agree and yet be wrong), inadequacy of definition of standards of care, and circularity in several definitions of preventability. Furthermore, attempts to list all preventable effects are bound to be incomplete and will not always apply to an individual case. We conclude that an approach based on analysis of the mechanisms of adverse reactions and their clinical features could be preferable; such an approach is described in a companion paper (Part II) in this issue of Drug Safety.

Entities:  

Mesh:

Year:  2010        PMID: 20925436     DOI: 10.2165/11538270-000000000-00000

Source DB:  PubMed          Journal:  Drug Saf        ISSN: 0114-5916            Impact factor:   5.606


  65 in total

1.  Suspected adverse drug events requiring emergency department visits or hospital admissions.

Authors:  R Raschetti; M Morgutti; F Menniti-Ippolito; A Belisari; A Rossignoli; P Longhini; C La Guidara
Journal:  Eur J Clin Pharmacol       Date:  1999-02       Impact factor: 2.953

2.  Readmissions and adverse drug reactions in internal medicine: the economic impact.

Authors:  H Dormann; A Neubert; M Criegee-Rieck; T Egger; M Radespiel-Tröger; T Azaz-Livshits; M Levy; K Brune; E G Hahn
Journal:  J Intern Med       Date:  2004-06       Impact factor: 8.989

Review 3.  Clarification of terminology in drug safety.

Authors:  Jeffrey K Aronson; Robin E Ferner
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

4.  [Validation of a measurement scale: example of a French Adverse Drug Reactions Preventability Scale].

Authors:  Pascale Olivier; Jacques Caron; Françoise Haramburu; Jean-Louis Imbs; Annie-Pierre Jonville-Béra; Georges Lagier; Catherine Sgro; Thierry Vial; Jean-Louis Montastruc; Maryse Lapeyr-Mestre
Journal:  Therapie       Date:  2005 Jan-Feb       Impact factor: 2.070

5.  Letter: Preventability of adverse drug reactions.

Authors:  J F Burnum
Journal:  Ann Intern Med       Date:  1976-07       Impact factor: 25.391

Review 6.  Potential risks and prevention, Part 2: Drug-induced permanent disabilities.

Authors:  W N Kelly
Journal:  Am J Health Syst Pharm       Date:  2001-07-15       Impact factor: 2.637

7.  Estimating hospital deaths due to medical errors: preventability is in the eye of the reviewer.

Authors:  R A Hayward; T P Hofer
Journal:  JAMA       Date:  2001-07-25       Impact factor: 56.272

Review 8.  Potential risks and prevention, Part 4: Reports of significant adverse drug events.

Authors:  W N Kelly
Journal:  Am J Health Syst Pharm       Date:  2001-08-01       Impact factor: 2.637

9.  Preventable medication-related events in hospitalised children in New Zealand.

Authors:  Desireé L Kunac; David M Reith
Journal:  N Z Med J       Date:  2008-04-18

10.  Incidence, preventability and consequences of adverse events in older people: results of a retrospective case-note review.

Authors:  Ali B A Sari; Alison Cracknell; Trevor A Sheldon
Journal:  Age Ageing       Date:  2008-03-10       Impact factor: 10.668

View more
  26 in total

1.  Prevention and pharmacovigilance: what should we do, what can we do?

Authors:  I Ralph Edwards
Journal:  Drug Saf       Date:  2012-02-01       Impact factor: 5.606

2.  Medication errors.

Authors:  Robin E Ferner
Journal:  Br J Clin Pharmacol       Date:  2012-06       Impact factor: 4.335

3.  A prospective analysis of the preventability of adverse drug reactions reported in Sweden.

Authors:  Henrik Lövborg; Linda Ring Eriksson; Anna K Jönsson; Thomas Bradley; Staffan Hägg
Journal:  Eur J Clin Pharmacol       Date:  2012-02-19       Impact factor: 2.953

4.  Optimizing pharmacotherapy in older patients: a European perspective.

Authors:  Denis O'Mahony; Antonio Cherubini; Mirko Petrovic
Journal:  Drugs Aging       Date:  2012-06-01       Impact factor: 3.923

5.  Preventability of drug-related harms - part II: proposed criteria, based on frameworks that classify adverse drug reactions.

Authors:  Jeffrey K Aronson; Robin E Ferner
Journal:  Drug Saf       Date:  2010-11-01       Impact factor: 5.606

6.  Assessment of a new instrument for detecting preventable adverse drug reactions.

Authors:  Raja Benkirane; Rachida Soulaymani-Bencheikh; Asmae Khattabi; Ghita Benabdallah; Loubna Alj; Houda Sefiani; Khedidja Hedna; Lahcen Ouammi; Sten Olsson; Shanti N Pal
Journal:  Drug Saf       Date:  2015-04       Impact factor: 5.606

7.  Pharmacovigilance and the null hypothesis: do we do much for public health?

Authors:  I Ralph Edwards; Ambrose Isah
Journal:  Drug Saf       Date:  2011-02-01       Impact factor: 5.606

8.  Characterization of adverse drug reactions causing admission to an intensive care unit.

Authors:  Camilo Rojas-Velandia; Jair Ruiz-Garzón; Juan-Carlos Moscoso-Alcina; Álvaro Vallejos-Narvaéz; Jenny Castro-Canoa; Yuri Bustos-Martínez; Max Flórez-Cutiva; Mabel Contreras-Muñoz; Jully-Carolina Gómez-Gil; Carlos-Alberto Calderón-Ospina
Journal:  Br J Clin Pharmacol       Date:  2017-01-10       Impact factor: 4.335

Review 9.  Adverse drug reactions.

Authors:  Jamie J Coleman; Sarah K Pontefract
Journal:  Clin Med (Lond)       Date:  2016-10       Impact factor: 2.659

10.  Inter-rater reliability of the assessment of adverse drug reactions in the hospitalised elderly.

Authors:  B Tangiisuran; V Auyeung; L Cheek; C Rajkumar; G Davies
Journal:  J Nutr Health Aging       Date:  2013       Impact factor: 4.075

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.